TAVR as WP said is a game changer but it is a long road ahead, many bridges to cross before we even dream of fda approval.
First let’s get the ip’s registered that will be a big step, that’s when we will see a deal done and I expect it will be a BIG deal. Then with a partner they can start looking at trials and work toward fda approval.
I have no knowledge of the process but I’m assuming it will be a little less complicated given tavr is now an excepts procedure and we have fda approval for for our patches.
Ann: Appendix 4C - quarterly, page-77
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.80 |
Change
0.020(0.20%) |
Mkt cap ! $207.1M | |||
| Open | High | Low | Value | Volume |
| $9.85 | $10.78 | $9.60 | $572.9K | 57.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5627 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 931 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |